Elite international athletes (UK athletes preparing for Olympic and Paralympic competition) completed a daily electronic questionnaire for 10 days following SARS-CoV-2 vaccination via a mobile phone application. Figure Prevalence and duration of SARS-CoV-2 vaccine side-effects in athletes and effect on sporting participation Show full caption (A) Prevalence and duration of Pfizer-BioNTech SARS-CoV-2 vaccine tozinameran (BNT162b2) side-effects in an elite international athlete cohort. 7 Gärtner BCMeyer T Vaccination in elite athletes. In conclusion, in elite athletes, vaccination against SARS-CoV-2 with the Pfizer-BioNTech vaccine tozinameran appears to be well tolerated and associated with few significant side-effects. This analysis should help to inform discussion regarding the risks and benefits of SARS-CoV-2 vaccination in the context of sport.

Source: The Guardian December 10, 2021 23:44 UTC